Stocks Ranked by
Funds New Positions

Filters

#	Name	Net new positions	New positions	Closed positions	6-month price change
851	851	13	26	13	-3%
852	852	13	34	21	-11%
853	853	13	22	9	-0.7%
854	854 Spyre Therapeutics SYRE $918M	13	34	21	-55%
855	855	13	23	10	+3%
856	856	13	29	16	-22%
857	857	13	23	10	-0.4%
858	858	13	29	16	-14%
859	859	13	24	11	+24%
860	860	13	20	7	-14%
861	EOS 861 Eaton Vance Enhance Equity Income Fund II EOS $1.13B	13	23	10	-5%
862	862	13	21	8	-6%
863	863	13	19	6	-14%
864	864	13	21	8	-5%
865	865	13	23	10	-3%
866	866	13	21	8	-11%
867	867	13	29	16	+7%
868	868	13	22	9	-0.7%
869	869	13	26	13	+174%
870	870	13	22	9	-10%
871	871	13	20	7	-2%
872	872	13	16	3	-5%
873	873	13	17	4	-18%
874	874	13	23	10	-5%
875	875	13	25	12	+2%